NEW YORK, June 15, 2023 — On June 14, 2023, the Museum of Modern Art hosted the 12th annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party. This event brought together members of the leveraged finance and private equity worlds. Over 1,000 people from over 100 companies attended the event, which raised a record $3.1 million to fund groundbreaking and optimistic melanoma research.
“I believe our industry understands the significant impact our support of cutting-edge research, leading to groundbreaking advancements in immunotherapies that have changed the way cancer is treated,” said Jeff Rowbottom, co-founder of the event. “Events like LFFM give everyone impacted by cancer – patients, survivors, and loved ones alike – hope that researchers will have the resources they need to continue to accelerate lifesaving research.”
All proceeds from LFFM support the Melanoma Research Alliance, the largest and highest-rated non-profit funder of melanoma research worldwide. MRA-funded researchers have been behind every significant advancement in melanoma research since 2007. Treatments pioneered in melanoma are now being used to treat patients with over 30 other cancer types.
Brendan Dillon (Veritas Capital) and Jeff Rowbottom (General Atlantic Credit), who battled melanoma, launched LFFM in 2011. Since then, more than $23 million has been raised to fund melanoma research that could save lives.
The event was co-chaired by Clare Bailhé (MidCap Financial), Brendan Dillon (Veritas Capital), Kerry Dolan (Brinley Partners), Lee Grinberg (Elliott Management), Matt Manin (Apollo), Erwin Mock (Thoma Bravo), George Mueller (KKR), Geoff Oltmans (Silver Lake), Kevin Pluff (HPS Investment Partners), Jeff Rowbottom (General Atlantic Credit), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), Trevor Watt (Hellman & Friedman), and Eric Wedel (Kirkland & Ellis).
Veritas Capital, HPS Investment Partners, General Atlantic, Kirkland & Ellis, Latham & Watkins, Simpson Thacher & Bartlett, and Apollo/MidCap are among the LFFM’s title sponsors this year.
Fitch Ratings, Goldman Sachs, and White & Case are some of the presenters. Below is a complete list of LFFM sponsors.
According to MRA Chief Executive Officer Marc Hurlbert, Ph.D., “We are making unprecedented progress in ending suffering and death due to melanoma with the assistance of the leveraged finance and private equity communities.” “We still have a long way to go, but with the support of LFFM and our other donors, we are making significant progress that gives patients and families more time and hope.”
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
 benefit and cocktail party. This event brought together members of the leveraged finance and private equity worlds. Over 1,000 people from over 100 companies attended the event, which raised a record $3.1 million to fund groundbreaking and optimistic melanoma research){kind=link}